28.02.2013 Views

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Structural Chromosome Rearrangements 169<br />

given accurate genetic counseling regarding their reproductive risks and options. In situations where<br />

a familial rearrangement is identified, it must be remembered that it is not just the immediate family<br />

but distant relatives as well who could be at risk for having children with unbalanced karyotypes and<br />

associated mental and/or physical abnormalities. By systematically karyotyping the appropriate individuals<br />

in each generation, all those with elevated reproductive risks can be identified and appropriately<br />

counseled regarding their risks and options. Although there has been some debate regarding the<br />

appropriateness <strong>of</strong> karyotyping the phenotypically normal minors <strong>of</strong> balanced carriers, 50% <strong>of</strong> whom<br />

would be expected to be balanced carriers themselves, there is a consensus that these children should<br />

be referred for appropriate genetic counseling when they reach reproductive age.<br />

<strong>The</strong> situation becomes a bit more complex when chromosome analysis <strong>of</strong> a bone marrow or tumor<br />

specimen results in an apparently balanced rearrangement, not associated with any particular neoplasm,<br />

in all cells examined. In these cases, it is imperative to ascertain whether such a rearrangement<br />

represents a patient-specific acquired change (which can then be monitored during treatment, remission,<br />

relapse, or any change in disease aggression) or a constitutional abnormality present from birth.<br />

<strong>The</strong> reasons for this are tw<strong>of</strong>old. First, from the point <strong>of</strong> view <strong>of</strong> the physician treating the patient, the<br />

presence <strong>of</strong> any acquired cytogenetic change is significant (see Chapters 15 and 16). Alternatively,<br />

demonstrating that the rearrangement is constitutional can be considered “good news,” because this<br />

means that there are, in fact, no acquired chromosomal changes. Second, and equally important,<br />

however, is to consider the potential reproductive consequences for the extended family. Because it<br />

is necessary to focus on the treatment <strong>of</strong> the patient’s cancer, and because many <strong>of</strong> these patients are<br />

elderly and well beyond childbearing age, reproductive issues associated with a familial chromosome<br />

rearrangement are frequently overlooked. It should be clear from this chapter, however, that these<br />

issues must be addressed. Genetic counseling is covered in detail in Chapter 20.<br />

De Novo Rearrangements<br />

Every chromosome rearrangement was at one time a new or de novo rearrangement that carried<br />

the risks associated with an undefined entity. Children who carry unbalanced rearrangements, regardless<br />

<strong>of</strong> whether they represent new mutations or an unbalanced form <strong>of</strong> a familial rearrangement,<br />

almost inevitably demonstrate an abnormal phenotype. An imbalance is an imbalance regardless <strong>of</strong><br />

how it arose.<br />

In contrast, accurate predictions regarding the phenotype <strong>of</strong> a child or fetus that carries an<br />

apparently balanced de novo chromosome rearrangement are more difficult to make. In this situation,<br />

we have no idea what has occurred at the molecular level within the rearrangement and we<br />

have no family members with the rearrangement from whom inferences can be made. <strong>The</strong> risk<br />

for an abnormal phenotype is therefore always higher for an individual with an apparently balanced<br />

de novo rearrangement than for an individual who has inherited a similar rearrangement<br />

from a normal parent. Obviously, these individuals also carry a significantly higher risk for<br />

phenotypic abnormalities than their chromosomally normal counterparts. Several population<br />

studies have shown, for example, that the incidence <strong>of</strong> de novo apparently balanced rearrangements<br />

among the mentally retarded is approximately seven times that reported in newborns (24).<br />

Apparently balanced de novo rearrangements detected at amniocentesis have also been associated<br />

with a risk for congenital abnormalities that is tw<strong>of</strong>old to threefold higher than that observed<br />

within the general population (1).<br />

A number <strong>of</strong> different mechanisms are thought to be responsible for the abnormal phenotypes<br />

observed in children with apparently balanced de novo rearrangements. One possibility is that the<br />

translocation is not truly balanced. As discussed above, structural rearrangements that appear balanced<br />

at the microscopic level might actually contain large duplications and/or deletions at the<br />

molecular level. Another possibility is that the rearrangement is “balanced” but a break has occurred<br />

within a critical gene or its surrounding regulatory sequences such that the gene product or its

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!